Retrophin Announces U.S. FDA Acceptance of NDA Filing for the New Formulation of Thiola® (tiopronin) in the Treatment of Cystinuria PDUFA date set for June 30, 2019 SAN DIEGO, Nov. 12, 2018 (GLOBE NEWSWIRE) -- Retrophin, Inc. (NASDAQ: RTRX) today announced that the U.S. Food and Drug Administration (FDA) has accepted for review...

Kidney Stones: Very Scary True Stories. And Entombed Mysteries. SALT LAKE CITY, Oct. 2, 2015 (GLOBE NEWSWIRE) -- It woke me up in the middle of the night. It left me gasping and sobbing. Screaming. Someone was sticking a knife in me and slowly turning...